keyword
https://read.qxmd.com/read/38704808/the-stua-transcription-factor-and-alternative-splicing-mechanisms-drive-the-levels-of-mapk-hog1-transcripts-in-the-dermatophyte-trichophyton-rubrum
#1
JOURNAL ARTICLE
Leonardo Martins-Santana, Monise Fazolin Petrucelli, Pablo R Sanches, Fausto Almeida, Nilce M Martinez-Rossi, Antonio Rossi
Trichophyton rubrum is a human fungal pathogen that causes dermatophytosis, an infection that affects keratinized tissues. Integrated molecular signals coordinate mechanisms that control pathogenicity. Transcriptional regulation is a core regulation of relevant fungal processes. Previous RNA sequencing data revealed that the absence of the transcription factor StuA resulted in the differential expression of the MAPK-related high glycerol osmolarity gene (hog1) in T. rubrum. Here we validated the role of StuA in regulating the transcript levels of hog1...
May 5, 2024: Mycopathologia
https://read.qxmd.com/read/38704366/an-oxylipin-signal-confers-protection-against-antifungal-echinocandins-in-pathogenic-aspergilli
#2
JOURNAL ARTICLE
Dante G Calise, Sung Chul Park, Jin Woo Bok, Gustavo H Goldman, Nancy P Keller
Aspergillus fumigatus is the leading causative agent of life-threatening invasive aspergillosis in immunocompromised individuals. One antifungal class used to treat Aspergillus infections is the fungistatic echinocandins, semisynthetic drugs derived from naturally occurring fungal lipopeptides. By inhibiting beta-1,3-glucan synthesis, echinocandins cause both fungistatic stunting of hyphal growth and repeated fungicidal lysis of apical tip compartments. Here, we uncover an endogenous mechanism of echinocandin tolerance in A...
May 4, 2024: Nature Communications
https://read.qxmd.com/read/38704133/bet-inhibition-decreases-hmgcs2-and-sensitizes-resistant-pancreatic-tumors-to-gemcitabine
#3
JOURNAL ARTICLE
Aubrey L Miller, Samuel C Fehling, Rebecca B Vance, Dongquan Chen, Eric Josh Brown, M Iqbal Hossain, Eric O Heard, Shaida Andrabi, Hengbin Wang, Eddy S Yang, Donald J Buchsbaum, Robert C A M van Waardenburg, Susan L Bellis, Karina J Yoon
Efforts to develop targetable molecular bases for drug resistance for pancreatic ductal adenocarcinoma (PDAC) have been equivocally successful. Using RNA-seq and ingenuity pathway analysis we identified that the superpathway of cholesterol biosynthesis is upregulated in gemcitabine resistant (gemR) tumors using a unique PDAC PDX model with resistance to gemcitabine acquired in vivo. Analysis of additional in vitro and in vivo gemR PDAC models showed that HMG-CoA synthase 2 (HMGCS2), an enzyme involved in cholesterol biosynthesis and rate limiting in ketogenesis, is overexpressed in these models...
May 2, 2024: Cancer Letters
https://read.qxmd.com/read/38704107/expression-and-function-of-nicotinic-acetylcholine-receptors-in-specific-neuronal-populations-focus-on-striatal-and-prefrontal-circuits
#4
REVIEW
Alice Abbondanza, Anna Urushadze, Amanda Rosanna Alves Barboza, Helena Janickova
Nicotinic acetylcholine receptors (nAChRs) are widely expressed in the central nervous system and play an important role in the control of neural functions including neuronal activity, transmitter release and synaptic plasticity. Although the common subtypes of nAChRs are abundantly expressed throughout the brain, their expression in different brain regions and by individual neuronal types is not homogeneous or incidental. In recent years, several studies have emerged showing that particular subtypes of nAChRs are expressed by specific neuronal populations in which they have major influence on the activity of local circuits and behavior...
May 2, 2024: Pharmacological Research: the Official Journal of the Italian Pharmacological Society
https://read.qxmd.com/read/38704100/non-oncogene-dependencies-novel-opportunities-for-cancer-therapy
#5
REVIEW
Tiziana Di Marco, Mara Mazzoni, Angela Greco, Giuliana Cassinelli
Targeting oncogene addictions have changed the history of subsets of malignancies and continues to represent an excellent therapeutic opportunity. Nonetheless, alternative strategies are required to treat malignancies driven by undruggable oncogenes or loss of tumor suppressor genes and to overcome drug resistance also occurring in cancers addicted to actionable drivers. The discovery of non-oncogene addiction (NOA) uncovered novel therapeutically exploitable "Achilles' heels". NOA refers to genes/pathways not oncogenic per sé but essential for the tumor cell growth/survival while dispensable for normal cells...
May 2, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38704052/metallofullerenol-alleviates-alcoholic-liver-damage-via-ros-clearance-under-static-magnetic-and-electric-fields
#6
JOURNAL ARTICLE
Haoyu Wang, Junqi Zhao, Shiliang Ji, Tingjun Liu, Zhisheng Chen, Zhen Huang, Yuhui Zang, Jiangning Chen, Junfeng Zhang, Zhi Ding
Alcoholic liver disease (ALD) is a common chronic redox disease caused by increased alcohol consumption. Abstinence is a major challenge for people with alcohol dependence, and approved drugs have limited efficacy. Therefore, this study aimed to explore a new treatment strategy for ALD using ferroferric oxide endohedral fullerenol (Fe3 O4 @C60 (OH)n ) in combination with static magnetic and electric fields (sBE). The primary hepatocytes of 8-9-week-old female BALB/c mice were used to evaluate the efficacy of the proposed combination treatment...
May 2, 2024: Free Radical Biology & Medicine
https://read.qxmd.com/read/38703967/pharmacokinetics-and-pharmacodynamics-of-standard-nerve-agent-medical-countermeasures-in-g%C3%A3-ttingen-minipigs
#7
JOURNAL ARTICLE
Jeffrey L Langston, Mark C Moffett, M Ross Pennington, Todd M Myers
Animal research continues to serve a critical role in the testing and development of medical countermeasures. The Göttingen minipig, developed for laboratory research, may provide many benefits for addressing research questions within chemical defense. Targeted development of the Göttingen minipig model could reduce reliance upon non-human primates, and improve study design, statistical power, and throughput to advance medical countermeasures for regulatory approval and fielding. In this vein, we completed foundational pharmacokinetics and physiological safety studies of intramuscularly administered atropine sulfate, pralidoxime chloride (2-PAM), and diazepam across a broad range of doses (1 to 6 autoinjector equivalent) using adult male Göttingen minipigs (n=11; n=4-8/study) surgically implanted with vascular access ports and telemetric devices to monitor cardiovascular, respiratory, arterial pressure, and temperature signals...
May 2, 2024: Toxicology Letters
https://read.qxmd.com/read/38703873/bioassay-guided-isolation-of-anti-inflammatory-and-antinociceptive-metabolites-among-three-moroccan-juniperus-leaves-extract-supported-with-in-vitro-enzyme-inhibitory-assays
#8
JOURNAL ARTICLE
Meryem El Jemli, Shahira M Ezzat, Mourad Kharbach, Eman Sherien Mostafa, Rasha Ali Radwan, Yousra El Jemli, Otman El-Guourrami, Samir Ahid, Yahia Cherrah, Ahmed Zayed, Katim Alaoui
ETHNOPHARMACOLOGICAL RELEVANCE: Herbs of the genus Juniperus (family Cupressaceae) have been commonly used in ancestral folk medicine known as "Al'Araar" for treatment of rheumatism, diabetes, inflammation, pain, and fever. Bioassay-guided isolation of bioactives from medicinal plants is recognized as a potential approach for the discovery of novel drug candidates. In particular, non-addictive painkillers are of special interest among herbal phytochemicals. AIM OF THE STUDY: The current study aimed to assess the safety of J...
May 2, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38703814/heat-shock-protein-72-supports-extracellular-matrix-production-in-metastatic-mammary-tumors
#9
JOURNAL ARTICLE
Benjamin J Lang, Kristina M Holton, Martin E Guerrero-Gimenez, Yuka Okusha, Patrick T Magahis, Amy Shi, Mary Neguse, Shreya Venkatesh, Anh M Nhu, Jason E Gestwicki, Stuart K Calderwood
This study identified tumorigenic processes most dependent on murine HSP72 in the MMTV-PyMT mammary tumor model, which give rise to spontaneous mammary tumors that exhibit HSP72-dependent metastasis to the lung. RNA-seq expression profiling of Hspa1a/Hspa1b (Hsp72) WT and Hsp72-/- primary mammary tumors discovered significantly lower expression of genes encoding components of the extracellular matrix (ECM) in Hsp72 knockout mammary tumors compared to WT controls. In vitro studies found that genetic or chemical inhibition of HSP72 activity in cultured collagen-expressing human or murine cells also reduces mRNA and protein levels of COL1A1 and several other ECM-encoding genes...
May 2, 2024: Cell Stress & Chaperones
https://read.qxmd.com/read/38703777/slower-cdk4-and-faster-cdk2-activation-in-the-cell-cycle
#10
JOURNAL ARTICLE
Wengang Zhang, Yonglan Liu, Hyunbum Jang, Ruth Nussinov
Dysregulation of cyclin-dependent kinases (CDKs) impacts cell proliferation, driving cancer. Here, we ask why the cyclin-D/CDK4 complex governs cell cycle progression through the longer G1 phase, whereas cyclin-E/CDK2 regulates the shorter G1/S phase transition. We consider available experimental cellular and structural data including cyclin-E's high-level burst, sustained duration of elevated cyclin-D expression, and explicit solvent molecular dynamics simulations of the inactive monomeric and complexed states, to establish the conformational tendencies along the landscape of the distinct activation scenarios of cyclin-D/CDK4 and cyclin-E/CDK2 in the G1 phase and G1/S transition of the cell cycle, respectively...
April 23, 2024: Structure
https://read.qxmd.com/read/38703767/assessing-personalized-responses-to-anti-pd-1-treatment-using-patient-derived-lung-tumor-on-chip
#11
JOURNAL ARTICLE
Irina Veith, Martin Nurmik, Arianna Mencattini, Isabelle Damei, Christine Lansche, Solenn Brosseau, Giacomo Gropplero, Stéphanie Corgnac, Joanna Filippi, Nicolas Poté, Edouard Guenzi, Anaïs Chassac, Pierre Mordant, Jimena Tosello, Christine Sedlik, Eliane Piaggio, Nicolas Girard, Jacques Camonis, Hamasseh Shirvani, Fathia Mami-Chouaib, Fatima Mechta-Grigoriou, Stéphanie Descroix, Eugenio Martinelli, Gérard Zalcman, Maria Carla Parrini
There is a compelling need for approaches to predict the efficacy of immunotherapy drugs. Tumor-on-chip technology exploits microfluidics to generate 3D cell co-cultures embedded in hydrogels that recapitulate simplified tumor ecosystems. Here, we present the development and validation of lung tumor-on-chip platforms to quickly and precisely measure ex vivo the effects of immune checkpoint inhibitors on T cell-mediated cancer cell death by exploiting the power of live imaging and advanced image analysis algorithms...
April 27, 2024: Cell reports medicine
https://read.qxmd.com/read/38703623/representations-of-alcohol-and-drug-use-in-the-finnish-reform-of-social-and-health-care-service-users-rights
#12
JOURNAL ARTICLE
Veera Kankainen, Anu Katainen, Lotta Hautamäki, Katariina Warpenius
BACKGROUND: A growing body of research has analysed the representations of alcohol and other drugs (AOD) in policy-making, but few studies have focused on the representations reproduced in law-making processes, especially in the context of the regulation of the rights of social and health care service users. This study examined what kind of representations of AOD use are reproduced in the legislative reform of social and health care service users' rights in Finland. The purpose of the reform is to strengthen social and health care service users' rights to self-determination and to reduce the use of restrictive measures...
May 3, 2024: International Journal on Drug Policy
https://read.qxmd.com/read/38703564/current-understanding-on-trem-2-molecular-biology-and-physiopathological-functions
#13
REVIEW
Shiv Bharadwaj, Yaroslava Groza, Joanna M Mierzwicka, Petr Malý
Triggering receptor expressed on myeloid cells 2 (TREM-2), a glycosylated receptor belonging to the immunoglobin superfamily and especially expressed in the myeloid cell lineage, is frequently explained as a reminiscent receptor for both adaptive and innate immunity regulation. TREM-2 is also acknowledged to influence NK cell differentiation via the PI3K and PLCγ signaling pathways, as well as the partial activation or direct inhibition of T cells. Additionally, TREM-2 overexpression is substantially linked to cell-specific functions, such as enhanced phagocytosis, reduced toll-like receptor (TLR)-mediated inflammatory cytokine production, increased transcription of anti-inflammatory cytokines, and reshaped T cell function...
May 3, 2024: International Immunopharmacology
https://read.qxmd.com/read/38703508/nicotinamide-riboside-attenuates-myocardial-ischemia-reperfusion-injury-via-regulating-sirt3-sod2-signaling-pathway
#14
JOURNAL ARTICLE
Kai Zhao, Jie Tang, Hong Xie, Lin Liu, Qin Qin, Bo Sun, Zheng-Hong Qin, Rui Sheng, Jiang Zhu
Ischemic heart disease invariably leads to devastating damage to human health. Nicotinamide ribose (NR), as one of the precursors of NAD+ synthesis, has been discovered to exert a protective role in various neurological and cardiovascular disorders. Our findings demonstrated that pretreatment with 200 mg/kg NR for 3 h significantly reduced myocardial infarct area, decreased levels of CK-MB and LDH in serum, and improved cardiac function in the rats during myocardial ischemia-reperfusion (I/R) injury...
May 3, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38703505/gonadal-efficacy-of-thymus-quinquecostatus-celakovski-regulation-of-testosterone-levels-in-aging-mouse-models
#15
JOURNAL ARTICLE
Hyun-Yong Kim, Hyuck Se Kwon, Je-Oh Lim, Hyun-Jun Jang, Subramanian Muthamil, Ung Cheol Shin, Ji-Hyo Lyu, Yeo Jin Park, Hyeon-Hwa Nam, Na-Young Lee, Hyun-Jeong Oh, Soon-Il Yun, Jong-Sik Jin, Jun Hong Park
Late-onset hypogonadism (LOH) is an age-related disease in men characterized by decreased testosterone levels with symptoms such as decreased libido, erectile dysfunction, and depression. Thymus quinquecostatus Celakovski (TQC) is a plant used as a volatile oil in traditional medicine, and its bioactive compounds have anti-inflammatory potential. Based on this knowledge, the present study aimed to investigate the effects of TQC extract (TE) on LOH in TM3 Leydig cells and in an in vivo aging mouse model. The aqueous extract of T...
May 3, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38703154/validating-human-induced-pluripotent-stem-cell-specific-quality-control-tests-for-the-release-of-an-intermediate-drug-product-in-a-good-manufacturing-practice-quality-system
#16
JOURNAL ARTICLE
Juan Novoa, Inge Westra, Esther Steeneveld, Natascha Fonseca Neves, Lizanne Daleman, Albert Blanch Asensio, Richard P Davis, Françoise Carlotti, Christian Freund, Ton Rabelink, Pauline Meij, Brigitte Wieles
One of the challenges in Good Manufacturing Practice (GMP)-compliant human induced pluripotent stem cell (hiPSC) production is the validation of quality control (QC) tests specific for hiPSCs, which are required for GMP batch release. This study presents a comprehensive description of the validation process for hiPSC-specific GMP-compliant QC assays; more specifically, the validation of assays to assess the potential presence of residual episomal vectors (REVs), the expression of markers of the undifferentiated state and the directed differentiation potential of hiPSCs...
April 14, 2024: Cytotherapy
https://read.qxmd.com/read/38702711/tribulations-and-future-opportunities-for-artificial-intelligence-in-precision-medicine
#17
REVIEW
Claudio Carini, Attila A Seyhan
Upon a diagnosis, the clinical team faces two main questions: what treatment, and at what dose? Clinical trials' results provide the basis for guidance and support for official protocols that clinicians use to base their decisions. However, individuals do not consistently demonstrate the reported response from relevant clinical trials. The decision complexity increases with combination treatments where drugs administered together can interact with each other, which is often the case. Additionally, the individual's response to the treatment varies with the changes in their condition...
April 30, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38702193/-comparison-of-the-cyp3a-selective-inhibitors-cyp3cide-clobetasol-and-azamulin-for-their-potential-to-distinguish-cyp3a7-activity-in-the-presence-of-cyp3a4-5
#18
JOURNAL ARTICLE
Hannah M Work, Sylvie E Kandel, Jed N Lampe
The CYP3A7 enzyme accounts for ~50% of the total CYP content in fetal and neonatal livers and is the predominant CYP involved in neonatal xenobiotic metabolism. Additionally, it is a key player in healthy birth outcomes through the oxidation of dehydroepiandrosterone (DHEA) and DHEA-S (sulfate). The amount of the other hepatic CYP3A isoforms, CYP3A4 and CYP3A5, expressed in neonates is low, but highly variable, and therefore the activity of individual CYP3A isoforms is difficult to differentiate due to their functional similarities...
May 3, 2024: Drug Metabolism and Disposition: the Biological Fate of Chemicals
https://read.qxmd.com/read/38701414/metabolic-models-predict-fotemustine-and-the-combination-of-eflornithine-rifamycin-and-adapalene-cannabidiol-for-the-treatment-of-gliomas
#19
JOURNAL ARTICLE
Ali Kishk, Maria Pires Pacheco, Tony Heurtaux, Thomas Sauter
Gliomas are the most common type of malignant brain tumors, with glioblastoma multiforme (GBM) having a median survival of 15 months due to drug resistance and relapse. The treatment of gliomas relies on surgery, radiotherapy and chemotherapy. Only 12 anti-brain tumor chemotherapies (AntiBCs), mostly alkylating agents, have been approved so far. Glioma subtype-specific metabolic models were reconstructed to simulate metabolite exchanges, in silico knockouts and the prediction of drug and drug combinations for all three subtypes...
March 27, 2024: Briefings in Bioinformatics
https://read.qxmd.com/read/38701407/abbv-319-a-cd19-targeting-glucocorticoid-receptor-modulator-antibody-drug-conjugate-therapy-for-b-cell-malignancies
#20
JOURNAL ARTICLE
Chewei Anderson Chang, Ethan Emberley, Aloma L D'Souza, Weilong Zhao, Cormac Cosgrove, Karen E Parrish, Diya Mitra, Elmer Payson, Anatol Oleksijew, Paul Ellis, Luis Rodriguez, Ryan Duggan, Cara Hrusch, Loren Lasko, Wissam Assaily, Pingping Zheng, Wei Liu, Axel Hernandez, Kimberley McCarthy, Zhaomei Zhang, Geunbae Rha, Zhensheng Cao, Yingchun Li, Olivia Perng, Jos Campbell, Gloria Zhang, Tyler Scott Curran, Milan Bruncko, Christopher C Marvin, Adrian D Hobson, Michael McPherson, Tamar Uziel, Marybeth A Pysz, Xi Zhao, Alexander Bankovich, Joel Hayflick, Michael McDevitt, Kevin J Freise, Susan Morgan-Lappe, James W Purcell
Glucocorticoids are key components of the current standard-of-care regimens (e.g., R-CHOP, EPOCH-R, Hyper-CVAD) for treatment of B-cell malignancy. However, systemic glucocorticoid treatment is associated with several adverse events. CD19 displays restricted expression in normal B-cells and is up-regulated in B-cell malignancies. ABBV-319 is a CD19-targeting antibody-drug conjugate (ADC) engineered to reduce glucocorticoid-associated toxicities while possessing three distinct mechanisms of action (MOA) to increase therapeutic efficacy: (1) antibody-mediated delivery of glucocorticoid receptor modulator (GRM) payload to activate apoptosis, (2) inhibition of CD19 signaling, and (3) enhanced Fc-mediated effector function via afucosylation of the antibody backbone...
May 3, 2024: Blood
keyword
keyword
20551
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.